All In Biotech

NDA 016784 · B Braun

Glycine 1.5% In Plastic Container

Glycine · Irrigation

Last checked: Nov 20, 2026Latest source record: Sep 12, 2014 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1978

Feb 6, 1978

Approved uses

1

Original approval plus efficacy supplements

Registered trials

124

18 Phase 3, 9 recruiting

FAERS reports

329

262 serious, 28 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Apr 1, 2021.

INDICATIONS AND USAGE 1.5% Glycine Irrigation USP is indicated as an irrigant during transurethral prostatic or bladder surgery.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Feb 6, 1978 Original approval · Type 5 - New Formulation or New Manufacturer
1 products under this application
  • GLYCINE 1.5% IN PLASTIC CONTAINER · GLYCINE 1.5GM/100ML · SOLUTION, IRRIGATION · Prescription · TE AT

Clinical trials

Interventional ClinicalTrials.gov studies with "Glycine" as an intervention, any sponsor and status, largest first.

All 124 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective37
  • nausea29
  • pneumonia27
  • off label use26
  • fatigue25
  • condition aggravated24
  • rash23
  • insomnia22
  • status epilepticus22
  • stevens-johnson syndrome22
  • depressed level of consciousness21
  • sopor21

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20051
20091
20102
20111
201210
201310
20145
201511
201618
201735
201838
201911
202024
202120
202232
202325
202438
202527
202620

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 1,153 on PubMed

Sponsor: B Braun

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.